TipRanks
Advertisement
Advertisement
Lyell Immunopharma initiated with a Buy at Stifel
PremiumThe FlyLyell Immunopharma initiated with a Buy at Stifel
3M ago
Lyell Immunopharma initiated with a Buy at B. Riley
Premium
The Fly
Lyell Immunopharma initiated with a Buy at B. Riley
3M ago
Lyell Immunopharma files to sell 1.1M shares of common stock for holders
Premium
The Fly
Lyell Immunopharma files to sell 1.1M shares of common stock for holders
3M ago
Lyell Immunopharma provides update on safety profile of LYL273
PremiumThe FlyLyell Immunopharma provides update on safety profile of LYL273
5M ago
Lyell Gains Buy Rating on Leadership in CD19/20 CAR-T and Ronde-cel Progress; Analyst Reiterates $45 Price Target
Premium
Ratings
Lyell Gains Buy Rating on Leadership in CD19/20 CAR-T and Ronde-cel Progress; Analyst Reiterates $45 Price Target
6M ago
Lyell Immunopharma initiated with an Outperform at Baird on ronde-cel potential
Premium
The Fly
Lyell Immunopharma initiated with an Outperform at Baird on ronde-cel potential
6M ago
Lyell Immunopharma: Undervalued CAR-T Innovator With Strong Ronde-cel Profile, Hidden LYL273 Upside, and Cash Runway to 2027 Supporting Buy Rating and $44 Target
PremiumRatingsLyell Immunopharma: Undervalued CAR-T Innovator With Strong Ronde-cel Profile, Hidden LYL273 Upside, and Cash Runway to 2027 Supporting Buy Rating and $44 Target
6M ago
Lyell Immunopharma initiated with a Buy at Needham
Premium
The Fly
Lyell Immunopharma initiated with a Buy at Needham
6M ago
Lyell Immunopharma: Differentiated Dual‑Target CAR‑T Pipeline and Upcoming Clinical Milestones Support Buy Rating and Acquisition Potential
Premium
Ratings
Lyell Immunopharma: Differentiated Dual‑Target CAR‑T Pipeline and Upcoming Clinical Milestones Support Buy Rating and Acquisition Potential
7M ago

Trending

Name
Price
Price Change
S&P 500
―
Dow Jones
―
Nasdaq 100
―